|Study Type:||Phase Ib|
|Stage:||Primary analysis complete|
|Study Start Date:||NA|
|Study Made Public:||NA|
A Phase 1b clinical trial to evaluate mucosal immune responses to a DNA plasmid vaccine prime followed by an HIV-1 adenoviral vector boost in healthy adenovirus type 5 seronegative HIV-1-uninfected adults
HVTN 076 is a Phase Ib clinical trial to evaluate the safety and immunogenicity of VRC-HIVDNA-016-00-VP (DNA) prime / VRCHIVADV014-00-VP (rAd5) boost.
Sign in to see full information about this study and to download study data.
ProductsProduct info coming soon!
No integrated data is available for this study.
No non-integrated data is available for this study.